FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Jul 3, 2025
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on July 3, 2025, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · 8f57693f-a1d8-4fed-9d81-69de6e1fbea1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1274630
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ImpactLife
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 26, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 1, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 7, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1106877 - 2019-09-12
- FDA Inspection 1026192 - 2017-07-18
- FDA Inspection 921394 - 2015-03-26
- FDA Inspection 828694 - 2013-05-01
- FDA Inspection 700491 - 2010-12-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.